What causes ttts

Overview

Twin-to-Twin Transfusion Syndrome (TTTS) is a serious complication that can occur in monochorionic pregnancies, meaning pregnancies where identical twins share a single placenta. This shared placental environment is the root cause, as an abnormal connection of blood vessels within the placenta can lead to an unequal sharing of blood supply between the twins. One twin, known as the 'recipient' twin, receives an excessive amount of blood, while the other, the 'donor' twin, receives too little.

What Causes TTTS?

The primary cause of TTTS lies in the abnormal vascular connections (anastomoses) between the twins' circulations within the shared placenta. In a typical monochorionic pregnancy, there are usually balanced connections that allow for adequate blood flow to both fetuses. However, in TTTS, there is an imbalance in these vascular connections. These connections can be artery-to-vein (AV), vein-to-vein (VV), or artery-to-artery (AA), with AV anastomoses being the most common and significant contributors to TTTS. When these connections are unbalanced, blood is shunted from one twin to the other. The recipient twin receives too much blood volume, leading to conditions like polyhydramnios (excess amniotic fluid), cardiac strain, and potential organ damage. Conversely, the donor twin suffers from insufficient blood volume, resulting in oligohydramnios (low amniotic fluid), intrauterine growth restriction (IUGR), and dehydration.

Risk Factors and Development

While the exact trigger for the development of these abnormal vascular connections is not fully understood, certain factors are associated with an increased risk. TTTS occurs exclusively in monochorionic pregnancies, specifically monochorionic-monoamniotic (MCMA) and monochorionic-diamniotic (MCDA) twins. MCMA twins, who share both a placenta and an amniotic sac, have a higher risk of developing TTTS compared to MCDA twins, although MCDA twins are more common. The syndrome can manifest at any stage of pregnancy, but it is most frequently diagnosed between 16 and 26 weeks gestation. The progression of TTTS can be rapid, and if left untreated, it can lead to severe morbidity and mortality for one or both twins.

Symptoms and Diagnosis

Recognizing the signs of TTTS is crucial for timely intervention. Symptoms can vary and may not always be apparent to the mother. However, healthcare providers monitor for specific indicators during routine prenatal care. These include:

• Significant differences in fetal growth between the twins.
• Discrepancies in amniotic fluid levels (polyhydramnios in the recipient, oligohydramnios in the donor).
• Fetal heart abnormalities, such as cardiomegaly (enlarged heart) in the recipient twin.
• Changes in fetal behavior, like decreased movement in the donor twin.
• Maternal symptoms like sudden weight gain or abdominal discomfort due to increased amniotic fluid.

Diagnosis is typically made through serial ultrasounds. High-resolution ultrasound allows for detailed examination of placental vascularity, amniotic fluid volumes, fetal growth, and fetal anatomy. Doppler ultrasound is also used to assess blood flow within the umbilical cord and fetal circulation, helping to identify imbalances.

Treatment and Management

The management of TTTS depends on the severity and gestational age at diagnosis. Treatment aims to rebalance blood flow and improve the chances of survival and healthy development for both twins. Common treatment options include:

• Laser Ablation of Placental Vessels: This minimally invasive surgical procedure uses an endoscope to locate and seal the abnormal blood vessel connections within the placenta, effectively separating the twins' circulations. It is often considered the most effective treatment.
• Amnioreduction: This involves draining excess amniotic fluid from the sac of the recipient twin to relieve pressure on the placenta and uterus, thereby improving placental function.
• Fetal Shunt Placement (Septostomy): A small tube is inserted to create a connection between the amniotic sacs, allowing amniotic fluid to move more freely between the twins and potentially rebalance fluid levels.
• Supportive Care: In some very early or mild cases, close monitoring with serial ultrasounds may be sufficient, with interventions considered if the condition progresses.

The prognosis for TTTS has improved significantly with advances in diagnosis and treatment. However, even with successful intervention, both twins are at risk for long-term complications, including neurological issues, vision problems, and developmental delays. Close follow-up care throughout pregnancy and after birth is essential for monitoring the health and development of the surviving twins.